Glucocorticoid discontinuation in patients with SLE with prior severe organ involvement: a single-center retrospective analysis

Ítems similars

• Glucocorticoid discontinuation in patients with SLE with prior severe organ involvement: a single-center retrospective analysis
  per: Masato Okada, et al.
  Publicat: (2022-05-01)
• LSO-088 Ld-IL2 synthesis with belimumab in the treatment of systemic lupus erythematosus patients
  per: Ruiling Feng
  Publicat: (2023-07-01)
• Long-term safety and efficacy of the combination of belimumab and rituximab in the treatment of severe and refractory SLE: a preliminary report
  per: Tineke Kraaij, et al.
  Publicat: (2025-02-01)
• Safety and efficacy of belimumab in older adults with SLE: results of an integrated analysis of clinical trial data
  per: Anne Hammer, et al.
  Publicat: (2023-01-01)
• Belimumab as a possible treatment for SLE-associated pulmonary arterial hypertension: the experience from a single centre
  per: Qiang Wang, et al.
  Publicat: (2026-06-01)